全文获取类型
收费全文 | 5863篇 |
免费 | 648篇 |
国内免费 | 234篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 119篇 |
妇产科学 | 39篇 |
基础医学 | 1249篇 |
口腔科学 | 321篇 |
临床医学 | 509篇 |
内科学 | 1337篇 |
皮肤病学 | 265篇 |
神经病学 | 288篇 |
特种医学 | 77篇 |
外科学 | 332篇 |
综合类 | 842篇 |
预防医学 | 187篇 |
眼科学 | 72篇 |
药学 | 554篇 |
中国医学 | 235篇 |
肿瘤学 | 288篇 |
出版年
2024年 | 1篇 |
2023年 | 64篇 |
2022年 | 71篇 |
2021年 | 174篇 |
2020年 | 164篇 |
2019年 | 254篇 |
2018年 | 263篇 |
2017年 | 237篇 |
2016年 | 213篇 |
2015年 | 214篇 |
2014年 | 406篇 |
2013年 | 360篇 |
2012年 | 333篇 |
2011年 | 380篇 |
2010年 | 294篇 |
2009年 | 239篇 |
2008年 | 255篇 |
2007年 | 236篇 |
2006年 | 209篇 |
2005年 | 215篇 |
2004年 | 218篇 |
2003年 | 308篇 |
2002年 | 291篇 |
2001年 | 216篇 |
2000年 | 175篇 |
1999年 | 200篇 |
1998年 | 167篇 |
1997年 | 131篇 |
1996年 | 82篇 |
1995年 | 56篇 |
1994年 | 55篇 |
1993年 | 47篇 |
1992年 | 30篇 |
1991年 | 34篇 |
1990年 | 26篇 |
1989年 | 28篇 |
1988年 | 18篇 |
1987年 | 10篇 |
1986年 | 11篇 |
1985年 | 43篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 4篇 |
1981年 | 1篇 |
1980年 | 1篇 |
排序方式: 共有6745条查询结果,搜索用时 31 毫秒
91.
Satoko Takizawa Hiroshi Ozaki Hideaki Karaki 《European journal of pharmacology》1997,330(2-3):143-150
Stimulation of vascular smooth muscle by bacterial lipopolysaccharide has been shown to produce interleukin-1β and to induce vasodilation in septic shock. To understand the mechanisms of interleukin-1β-induced relaxation, we examined the effects of interleukin-1β on contractility and cyclic GMP contents of vascular smooth muscle. After treatment of the rat aorta with interleukin-1β (20 ng/ml) for 6 h, the cyclic GMP content increased and the contraction induced by phenylephrine (1 μM) was partially inhibited. An inhibitor of nitric oxide (NO) synthase, NG-monomethyl-
-arginine (
-NMMA, 100 μM), prevented the inhibitory effect of interleukin-1β. After treatment with interleukin-1β for 24 h, the phenylephrine-induced contraction was inhibited more strongly. Neither
-NMMA (100 μM) nor aminoguanidine (100 μM) reversed the inhibition, whereas methylene blue (10 μM) partially reversed the inhibition. After treatment with interleukin-1β for 12 or 24 h, the cyclic GMP content increased but to a level lower than that obtained with a 6-h treatment. The effects of sodium nitroprusside (1 μM) to inhibit the phenylephrine-induced contraction and to increase the cyclic GMP content were markedly suppressed by the 24-h interleukin-1β treatment. In contrast, the 24-h interleukin-1β treatment did not change the ability of 8-bromo-cGMP to relax the phenylephrine-stimulated aorta. Addition of
-NMMA (1 mM) during the 24 h treatment prevented NO production and preserved the sodium nitroprusside-induced cGMP generation by interleukin-1β. The 24 h interleukin-1β treatment increased the threshold concentration of KCl needed to induce contraction without changing the maximum contraction. In the presence of 25.4 mM KCl or the non-selective K+ channel inhibitor, tetraethylammonium, the inhibitory effect of the 24-h interleukin-1β treatment on phenylephrine-induced contraction was restored. These results suggest that interleukin-1β inhibits vascular smooth muscle contraction by a time-dependent, dual mechanism. After a 6-h treatment with interleukin-1β, the NO/cyclic GMP system is activated. After a 24-h interleukin-1β treatment, in contrast, the NO/cyclic GMP system may be desensitized and the contraction of vascular smooth muscle is inhibited by another mechanism, possibly membrane hyperpolarization. 相似文献
Full-size image
Full-size image
Full-size image
Full-size image
92.
Nicola J Jordan Malcolm L Watson Robert J Williams Alan G Roach Teizo Yoshimura John Westwick 《British journal of pharmacology》1997,122(4):749-757
- The production of chemokines by vascular smooth muscle cells (SMC) is implicated in the pathogenesis of atherosclerosis, although the factors regulating chemokine production by these cells are incompletely characterized.
- We describe the differential stimulation of interleukin-(IL)-8, monocyte chemoattractant protein (MCP)-1 and regulated on activation normal T-cell expressed and secreted (RANTES) synthesis following treatment of human vascular SMC with IL-1α or tumour necrosis factor α (TNFα). Under basal conditions, cultured SMC release very low amounts of IL-8, MCP-1 and RANTES as assessed by specific ELISA. Concentration-response studies with IL-1α or TNFα revealed that each stimulus induced a similar amount of MCP-1. In contrast approximately three fold more IL-8 was induced by IL-1α than by TNFα whereas significant RANTES production was induced only by TNFα. These findings point to a divergence in the regulation of synthesis of the different chemokines in response to IL-1α or TNFα stimulation.
- The T-cell derived cytokines IL-10 and IL-13 were also found to have differential effects on chemokine production by SMC. IL-13, but not IL-10, significantly enhanced IL-8 and MCP-1 release in response to IL-1α or TNFα. This increase in chemokine release appeared to be accounted for by increased mRNA expression.
- These findings provide support for the concept that smooth muscle cells can have an active role in a local immune response via the production of chemokines which can be selectively modulated by T-cell derived cytokines.
93.
M. H. özörnek P. Bielfeld J. S. Krüssel M. Moustafa B. Mikat-Drozdzynski U. Koldovsky U. Kuhn 《Journal of assisted reproduction and genetics》1995,12(9):590-593
Purpose
The aim of our study is to elucidate whether human oocyteslembryos secrete IFN
and/or IL-10 and whether the fertilization process depends on the balance between these cytokines.Methods
A total of 142 embryo culture media from 24 patients were collected and the cytokine levels were tested with ELISA.Results
IFN
and IL-10 were detectable in 40.1% and 29.6% of culture media respectively. The difference of IFN
and IL-10 levels in media from fertilized oocytes between day 1 and day 2 are significant (0.46 vs. 1.47 and 34.2 vs. 12.7, respectively). However there was no significant difference between the IFN
levels of the media from fertilized and nonfertilized oocytes 0.46 vs. 0.85 at day 1 and 1.47 vs. 1.49 at day 2, as well as IL-10 levels 34.2 vs. 30.9 at day 1 and 12.7 vs. 9.58 at day 2 respectively.Conclusions
Human preimplantation embryos secrete the cytokines IFN
and IL-10. No effect of these cytokines on fertilization process could be shown.Presented at the IXth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, April 3–7, 1995, Vienna, Austria. 相似文献
94.
G. Mantovani A. Macciò R. Versace M. Pisano P. Lai S. Esu M. Ghiani D. Dessì E. Turnu M. C. Santona R. Cherchi G. S. Del Giacco 《Journal of molecular medicine (Berlin, Germany)》1995,73(8):409-416
This work was designed to study the proliferative response of tumor-associated lymphocytes (TAL) from neoplastic effusions against autologous tumor cells and the immunophenotype pattern of TAL from neoplastic effusions and that of PBMC of the same patients. We also compared the serum levels of the cytokines interleukin (IL) 1, 2 and 6, tumor necrosis factor- (TNF) and soluble IL-2 receptor (sIL-2R) with those present in neoplastic effusions of the same patients. Moreover, we examined the ability of TAL and peripheral blood mononuclear cells (PBMC) to produce and release the cytokines and sIL-2R and to express membrane CD25 following their stimulation with phytohemagglutinin (PHA) in vitro. Finally, we compared the cytokines/sIL-2R production and membrane CD25 expression by PHA-stimulated PBMC of the patients with neoplastic effusions with a series of 90 cancer patients without neoplastic effusions and 20 normal healthy subjects. Thirteen neoplastic pleural and eight peritoneal effusions were collected from 11 patients with primary lung cancer, 7 with primary epithelial ovarian cancer, 1 with breast cancer, 1 with pleural mesothelioma, and 1 with pancreatic cancer. The proliferative response of TAL from neoplastic effusions against autologous tumor cells was lower than the response to PHA, IL-2, and anti-CD3, but significant. The percentage distribution of CD3+ and CD8+ lymphocyte subpopulations was higher in peritoneal than in pleural effusions, while the CD16+ subset was higher in pleural than in peritoneal effusions. The percentage distribution of CD16+ was significantly lower in pleural effusions than in PBMC of patients with pleural effusions. The CD39 antigen was higher on TAL from peritoneal effusions than on PBMC of the same patients. The levels of IL-1 and sIL-2R in peritoneal effusions did not differ from those measured in the sera of the same patients, while the levels of IL-2, IL-6, and TNF were higher in the peritoneal effusions. The levels of IL-2, IL-6, TNF, and sIL-2R, but not IL-1, in pleural effusions were significantly higher than those found in the sera of the same patients. The amounts of IL-2 and IL-6 produced by TAL were generally higher than those released by PBMC. The secretion of cytokines IL-1, IL-2, and sIL2R by PHA-stimulated PBMC was lower, but IL-1 and IL-6 secretion was higher in cancer patients with neoplastic effusions than in either cancer patients without neoplastic effusions or normal subjects. The CD25 expression on PHA-stimulated PBMC derived from cancer patients with neoplastic effusions was in the same range as that of cancer patients without neoplastic effusions and normal subjects. These findings suggest that TAL may be able to produce cytokines and may be amenable to immune manipulation.Abbreviations
FITC
Fluorescein-isothiocyanate
-
IL
Interleukin
-
mAb
Monoclonal antibody
-
MHC
Major histocompatibility complex
-
NK
Natural killer
-
PBMC
Peripheral blood mononuclear cells
-
PHA
Phytohemagglutinin
-
TAL
Tumor-associated lymphocytes
-
TIL
Tumor-infiltrating lymphocytes
-
TNF
Tumor necrosis factor-
-
sIL-2R
Soluble interleukin-2 receptor 相似文献
95.
目的:探讨白细胞介素1受体拮抗剂(interleukin1receptorantagonist,IL1ra)治疗博莱霉素(bleomycin,BLM)致大鼠肺纤维化模型的作用机制。方法:利用MTT法测定经IL1ra作用前、后1周时该模型大鼠肺泡巨噬细胞产生肿瘤坏死因子α(tumornecrosisfactorα,TNFα),及其培养上清促肺成纤维细胞增殖能力的变化;利用Northern杂交测定肺泡巨噬细胞TNFα、血小板衍化生长因子(plateletderivedgrowthfactor,PDGF)mRNA的表达。结果:BLM致肺纤维化模型1周时,肺泡巨噬细胞TNFα的产生及该组细胞上清的促成纤维细胞增殖活性与正常对照组相比均明显增强,而IL1ra(10mg·L-1)对肺泡巨噬细胞TNFα的产生及该组细胞上清的促成纤维细胞增殖活性有明显的抑制作用。BLM致肺纤维化模型1周时肺泡巨噬细胞TNFα、PDGFmRNA的表达较正常对照组增高,而IL1ra对其表达无明显影响。结论:IL1ra通过对肺泡巨噬细胞的TNFα产生及其对成纤维细胞增殖活性的抑制,可能对该模型的肺纤维化起到抑制作用 相似文献
96.
目的:为了研究增强rIL- 2 激活的骨髓细胞(激活骨髓ABM)的抗白血病效应。方法:应用抗CD3 单抗与rIL- 2 联合作用体外激活骨髓细胞,采用MTT比色分析法测定不同条件下ABM杀伤肿瘤细胞活性。结果:rIL- 2、抗CD3 单抗+ rIL- 2 体外诱导3 d 的ABM 杀伤活性分别为56.4% ±9.0% ,65.8% ±9.2% ,两组相比差异显著(P< 0.01);体外诱导7 d 细胞增殖倍数分别为3.7,6.0 倍。结论:在合理的诱导条件下,能够增强ABM 的杀伤活性,扩大ABM 的增殖效应,从而使有限的骨髓细胞在短期内达到有效的治疗剂量 相似文献
97.
98.
Theophylineisoneofthemostwidelyuseddrugsintreatingchronicobstructivepulmonarydisease(COPD).However,thetraditionaltheorythatth... 相似文献
99.
目的 探讨血清可溶性白细胞介素2 受体(s I L2 R)水平与恶性肿瘤患者的病期及疗效的关系。方法 采用双抗体夹心 E L I S A 法检测159 例恶性肿瘤患者放疗前后血清s I L2 R 水平。结果 恶性肿瘤患者放疗前血清s I L2 R 水平明显高于正常对照组( P< 005);放疗后血清s I L2 R 水平明显低于放疗前( P < 0001);晚期患者(Ⅲ+ Ⅳ期)不论是放疗前或放疗后 s I L2 R 水平均明显高于早期患者(Ⅰ+ Ⅱ期)( P < 005);各类恶性肿瘤之间血清s I L2 R 水平无显著性差异( P >005)。结论 s I L2 R水平在各种恶性肿瘤中的表达无特异性;检测恶性肿瘤患者s I L2 R 放疗前后水平,是对病情估计和治疗疗效评价的一项参考指标。 相似文献
100.
目的探讨冠心病病人外周血淋巴细胞补体Ⅰ型受体(CR1)表达及血清可溶性白细胞介素-2受体(sIL-2R)浓度的变化。②方法采用淋巴细胞花环试验和酶联免疫吸附法(ELISA),检测了72例冠心病病人和63例健康人淋巴细胞CR1花环率(L-CR1R)及血清sIL-2R浓度变化。③结果冠心病病人L-CR1R明显降低,sIL-2R浓度明显增高,与对照组比较差异有极显著性(t=6.414,7.806,P<0.001)。冠心病病人L-CR1R与sIL-2R呈负相关(r=-0.815,P<0.001)。不稳定心绞痛(UA)、急性心肌梗死(AMI)和陈旧性心肌梗死(OMI)病人L-CR1R和sIL-2R比较,差异亦具有极显著性(F=7.860,11.579,q=6.627~10.550,P<0.001),且以AMI病人的变化最明显。④结论外周血淋巴细胞CR1表达和血清sIL-2R浓度异常与冠心病病情变化有密切关系。 相似文献